Priority 17 from the Autosomal Dominant Polycystic Kidney Disease Project
| UNCERTAINTY: Why do the symptoms and severity of polycystic liver disease (PLD) vary between people? (Priority 17) | |
|---|---|
| Overall ranking | 17 |
| JLA question ID | 0103/17 |
| Explanatory note | Not available for this PSP |
| Evidence |
No evidence identified |
| Health Research Classification System category | Renal and urogenital |
| Extra information provided by this project | |
|---|---|
| Original uncertainty examples | How does liver size, in people with ADPKD, correlate with the symptoms of Polycystic liver disease and quality of life? ~ What are the effects of hormonal therapies including low-dose oral contraceptives, topical estrogens and hormonal replacement therapy on liver cyst growth in people with ADPKD? |
| Submitted by | Autosomal Dominant Polycystic Kidney Disease (ADPKD): Report from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference (.PDF) |
| Project information | |
|---|---|
| Project unique ID | 0103 |
| Project name | Autosomal Dominant Polycystic Kidney Disease |
| Total number of uncertainties identified by this project. |
35 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website) |
| Date of priority setting workshop | 15 December 2020 |